Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM97A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,134
Award facts
- Contract value 100% obligated
- $71,134.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $71,134.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 11, 2026, for RINVOQ ER 30 MG tablets (30-count unit of use).
Place of performance is Conshohocken, PA. The order has an ultimate completion date of May 12, 2026. No set-aside applies. AmerisourceBergen operates as the execution entity for DLA pharmaceutical distribution under its parent company Cencora, Inc.
Quick answers
Who was awarded contract SPE2DR26FM97A?
SPE2DR26FM97A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 11, 2026.
How much is contract SPE2DR26FM97A worth?
The government has obligated $71,134 on SPE2DR26FM97A.
Is contract SPE2DR26FM97A an order under another contract?
Yes. SPE2DR26FM97A is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM97A competed?
The extent of competition for SPE2DR26FM97A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award